Furthermore, T cells from multiple sclerosis patients exhibit lower TCF7 expression than those from healthy individuals, and FTY720 treatment upregulates TCF7 expression in T cells from both healthy controls and patients. The gene discussed is TCF7; the disease is multiple sclerosis.